namita thapar's emcure pharma ipo opens: should you bid? | ipo #shorts
Published 1 month ago • 885 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
6:46
emcure pharma ipo lists at 30% premium | namita thapar & satish mehta share details | business news
-
0:59
namita thapar to gain ₹127.8 cr from emcure pharma ipo
-
3:45
emcure pharma ipo open for subscription today, all you need to know! | investors & valuation |et now
-
25:46
namita thapar-backed emcure pharma’s rs 1,952 cr ipo opens|management on post-ipo roadmap| ipo watch
-
13:51
unicommerce eyes global expansion ahead of ipo | n18v
-
16:22
10x growth story of emcure pharmaceuticals | shark tank judge ms. namita thapar
-
2:31
tomorrow inc: emcure heiress namita thapar on women entrepreneurs taking the helm
-
19:30
will you invest in shark tank's namita thapar's company. emcure pharma ipo to open on july 3rd
-
4:34
top 10 things to know about emcure pharmaceuticals ipo | namita thapar's emcure pharma ipo review
-
5:44
emcure pharma ipo launch: what to expect? market expert sneha poddar analysis the ipo debut
-
3:00
emcure pharma ipo launches today; everything you need to know about the pharma company
-
39:25
live: namita thapar-backed emcure pharma ipo to debut on the bourses | ipo listing | n18l |cnbc tv18
-
1:14
namita thapar-backed emcure pharma ipo to fetch her 127 cr on exit
-
3:06
akums drugs & pharma ipo opens today for subscription, price band fixed at ₹646-679/sh | cnbc tv18
-
7:44
emcure pharma ipo to open next week, rationale behind the fundraise & utilization plans | et now
-
8:41
emcure pharma ipo oversubscribed; growth & expansion plans | samit mehta & vikas thapar | et now
-
5:08
emcure pharma ipo: namita thappar on tie up with sanofi & in-house products for cardiac segment
-
6:57
akums drugs and pharmaceuticals ipo - apply or avoid? akums drugs and pharmaceuticals ipo analysis
-
16:05
emcure pharma ipo summary | ca rachana ranade
-
4:06
emcure pharma ipo: all you need to know before investing
-
17:12
namita thapar's emcure pharma ipo - apply or avoid? expected listing gain? vibhor varshney
-
4:17
emcure pharmaceuticals ipo review | issue details, financials, products | namita thapar | must watch